News & Events

Kyowa Kirin joins Vivli as its newest member

“We are delighted to announce that global specialty pharmaceutical company, Kyowa Kirin, has joined Vivli as a member,” said Rebecca Li, Vivli Executive Director.

Kyowa Kirin strives to contribute to the health and well-being of people around the world through cutting-edge, technology-driven science, and will provide data focused on four key therapeutic areas: Nephrology, Oncology, Immunology & Allergy and Central Nervous System.

For more information about the data Kyowa Kirin will share on Vivli, please visit the member page. For additional information about Vivli membership, learn more here.